Antioxidative effects of erythropoietin

Kidney International

Volumn 72, Issue SUPPL. 107, 2007, Pages

  Katavetin, P ^a   Tungsanga, K ^a   Eiam Ong, S ^a   Nangaku, M ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cytoprotective; Erythropoietin; Heme oxygenase 1; Oxidative stress

Indexed keywords

ANTIOXIDANT; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR;

ANIMAL; APOPTOSIS; CELL PROTECTION; DRUG EFFECT; HUMAN; KIDNEY; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CYTOPROTECTION; ERYTHROPOIETIN; HUMANS; KIDNEY; RECEPTORS, ERYTHROPOIETIN;

EID: 35348964674     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002482     Document Type: Article

References (49)

1. Miyake T, Kung CK, Goldwasser E. Purification of human erythropoietin. J Biol Chem 1977; 252: 5558-5564. (Pubitemid 8167007)
2. Livnah O, Stura EA, Middleton SA et al. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 1999; 283: 987-990.
3. Silva M, Benito A, Sanz C et al. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 1999; 274: 22165-22169.
4. Damen JE, Mui AL, Puil L et al. Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. Blood 1993; 81: 3204-3210. (Pubitemid 23172900)
5. Masuda S, Nagao M, Takahata K et al. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 1993; 268: 11208-11216. (Pubitemid 23162313)
6. Tramontano AF, Muniyappa R, Black AD et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun 2003; 308: 990-994. (Pubitemid 36976556)
7. Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 1999; 55: 808-820. (Pubitemid 29100693)
8. Anagnostou A, Lee ES, Kessimian N et al. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990; 87: 5978-5982.
9. Bahlmann FH, Song R, Boehm SM et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 2004; 110: 1006-1012. (Pubitemid 39128626)
10. Kang DH, Park EY, Yu ES et al. Renoprotective effect of erythropoietin (EPO): possibly via an amelioration of renal hypoxia with stimulation of angiogenesis in the kidney. Kidney Int 2005; 67: 1683.
11. Lee SH, Li C, Lim SW et al. Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy. Am J Nephrol 2005; 25: 64-76. (Pubitemid 40529278)
12. Noiri E, Nagano N, Negishi K et al. Efficacy of darbepoetin in doxorubicin-induced cardiorenal injury in rats. Nephron Exp Nephrol 2006; 104: E6-E14.
13. Katavetin P, Inagi R, Miyata T et al. Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 2007; 359: 928-934. (Pubitemid 46946906)
14. Srisawat N, Manotham K, Kanjanabuch T et al. Amelioration of tubulointerstitial fibrosis by erythropoietin and carbamylated erythropoietin treatment. J Am Soc Nephrol 2006; 17 PUB127.
15. Fishbane S, Ragolia L, Palaia T et al. Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells. Kidney Int 2004; 65: 452-458. (Pubitemid 38130639)
16. Yang CW, Li C, Jung JY et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 2003; 17: 1754-1755.
17. Vesey DA, Cheung C, Pat B et al. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004; 19: 348-355. (Pubitemid 38195983)
18. Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-2124. (Pubitemid 39031350)
19. Spandou E, Tsouchnikas I, Karkavelas G et al. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant 2006; 21: 330-336. (Pubitemid 43159985)
20. Johnson DW, Pat B, Vesey DA et al. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 2006; 69: 1806-1813. (Pubitemid 43739209)
21. Abdelrahman M, Sharples EJ, McDonald MC et al. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004; 22: 63-69. (Pubitemid 40228212)
22. Miyoshi N, Oubrahim H, Chock PB, Stadtman ER. Age-dependent cell death and the role of ATP in hydrogen peroxide-induced apoptosis and necrosis. Proc Natl Acad Sci USA 2006; 103: 1727-1731. (Pubitemid 43228761)
23. Inal M, Kanbak G, Sen S et al. Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietinvitamin E combined therapy. Free Radic Res 1999; 31: 211-216. (Pubitemid 29435883)
24. Usberti M, Gerardi G, Bufano G et al. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis 2002; 40: 590-599. (Pubitemid 34971289)
25. Mimic-Oka J, Simic T, Djukanovic L. Epoetin treatment improves red blood cell and plasma antioxidant capacity in hemodialysis patients. Ren Fail 2002; 24: 77-87. (Pubitemid 34229601)
26. Calo LA, Stanic L, Davis PA et al. Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patients. Int J Clin Pharmacol Ther 2003; 41: 187-192. (Pubitemid 36603760)
27. Siems W, Carluccio F, Radenkovic S et al. Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment. Kidney Blood Press Res 2005; 28: 295-301.
28. Abraham NG, Nelson JC, Ahmed T et al. Erythropoietin controls heme metabolic enzymes in normal human bone marrow culture. Exp Hematol 1989; 17: 908-913. (Pubitemid 19217188)
29. Diaz Z, Assaraf MI, Miller Jr WH, Schipper HM. Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disorders. J Neurochem 2005; 93: 392-402. (Pubitemid 40547496)
30. Platt JL, Nath KA. Heme oxygenase: protective gene or Trojan horse. Nat Med 1998; 4: 1364-1365. (Pubitemid 28553454)
31. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005; 39: 1-25. (Pubitemid 40733115)
32. Deshane J, Wright M, Agarwal A. Heme oxygenase-1 expression in disease states. Acta Biochim Pol 2005; 52: 273-284. (Pubitemid 41133762)
33. Salinas M, Wang J, Rosa de Sagarra M et al. Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo. FEBS Lett 2004; 578: 90-94. (Pubitemid 39576106)
34. Lee TS, Chang CC, Zhu Y, Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 2004; 110: 1296-1302. (Pubitemid 39202348)
35. Calo LA, Davis PA, Piccoli A, Pessina AC. A role for heme oxygenase-1 in the antioxidant and antiapoptotic effects of erythropoietin: the start of a good news/bad news story? Nephron Physiol 2006; 103: P107-P111.
36. Genc S, Akhisaroglu M, Kuralay F, Genc K. Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine- induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci Lett 2002; 321: 73-76. (Pubitemid 34185502)
37. Kumral A, Gonenc S, Acikgoz O et al. Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 2005; 87: 15-18. (Pubitemid 40091371)
38. Bailey DM, Robach P, Thomsen JJ, Lundby C. Erythropoietin depletes iron stores: antioxidant neuroprotection for ischemic stroke? Stroke 2006; 37: 2453. (Pubitemid 44454657)
39. Bany-Mohammed FM, Slivka S, Hallman M. Recombinant human erythropoietin: possible role as an antioxidant in premature rabbits. Pediatr Res 1996; 40: 381-387. (Pubitemid 26282569)
40. Akisu M, Tuzun S, Arslanoglu S et al. Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants. Acta Med Okayama 2001; 55: 357-362.
41. Glass GA, Gershon D. Decreased enzymic protection and increased sensitivity to oxidative damage in erythrocytes as a function of cell and donor aging. Biochem J 1984; 218: 531-537.
42. Delmas-Beauvieux MC, Combe C, Peuchant E et al. Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron. Nephron 1995; 69: 404-410.
43. Canestrari F, Buoncristiani U, Galli F et al. Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients. Clin Chim Acta 1995; 234: 127-136.
44. Nemoto T, Yokota N, Keane WF, Rabb H. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int 2001; 59: 246-251. (Pubitemid 32055232)
45. Gong H, Wang W, Kwon TH et al. EPO and alpha-MSH prevent ischemia/ reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 2004; 66: 683-695. (Pubitemid 38982012)
46. Patel NS, Sharples EJ, Cuzzocrea S et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 2004; 66: 983-989. (Pubitemid 39121002)
47. Vaziri ND, Zhou XJ, Liao SY. Erythropoietin enhances recovery from cisplatin-induced acute renal failure. Am J Physiol 1994; 266: F360-F366.
48. Bagnis C, Beaufils H, Jacquiaud C et al. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 2001; 16: 932-938. (Pubitemid 32440364)
49. Andratschke N, Schnaitera A, Weber WA et al. Preclinical evaluation of erythropoietin administration in a model of radiation-induced kidney dysfunction. Int J Radiat Oncol Biol Phys 2006; 64: 1513-1518.